The epidemiological impact and significance of carbapenem resistance in <i>Pseudomonas aeruginosa</i> bloodstream infections: a matched case–case-control analysis

Abstract

A case-case-control investigation (N = 255 patients) explored the epidemiology of carbapenem-resistant Pseudomonas aeruginosa (CRPA). Recent exposure to carbapenems and a rapidly fatal condition should prompt practitioners to shorten delays in initiating appropriate therapy, which can adversely impact CRPA outcomes, as opposed to the isolated impact of the carbapenem resistance determinant.